Global Biosimilar Contract Manufacturing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Biosimilar Contract Manufacturing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The increasing popularity of?biosimilars?in treating diseases, such as cancer, autoimmune diseases, blood disorders, and others, and the low cost of biosimilars as compared to?biologics?are some of the major factors driving the market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Biosimilar Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biosimilar Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Biosimilar Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Biosimilar Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Biosimilar Contract Manufacturing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biosimilar Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biosimilar Contract Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim Biopharmaceuticals GmbH, Lonza, Catalent, Inc., Biocon, IQVIA Inc., AGC Biologics, Samsung Biologics, WuXi Biologics, Element Materials Technology, Rentschler Biopharma SE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biosimilar Contract Manufacturing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Recombinant Non-glycosylated Proteins
- Recombinant Glycosylated Proteins
Market segment by Application
- Oncology
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic & Autoimmune Disorders
- Rheumatoid Arthritis
- Others
Market segment by players, this report covers
- Boehringer Ingelheim Biopharmaceuticals GmbH
- Lonza
- Catalent, Inc.
- Biocon
- IQVIA Inc.
- AGC Biologics
- Samsung Biologics
- WuXi Biologics
- Element Materials Technology
- Rentschler Biopharma SE
- Avid Bioservices, Inc.
- Alcami Corporation, Inc.
- Fujifilm Kyowa Kirin Biologics Co., Ltd.
- Thermo Fisher Scientific Inc.
- Almac Group
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biosimilar Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilar Contract Manufacturing, with revenue, gross margin, and global market share of Biosimilar Contract Manufacturing from 2020 to 2025.
Chapter 3, the Biosimilar Contract Manufacturing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Biosimilar Contract Manufacturing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar Contract Manufacturing.
Chapter 13, to describe Biosimilar Contract Manufacturing research findings and conclusion.
The increasing popularity of?biosimilars?in treating diseases, such as cancer, autoimmune diseases, blood disorders, and others, and the low cost of biosimilars as compared to?biologics?are some of the major factors driving the market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Biosimilar Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biosimilar Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Biosimilar Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Biosimilar Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Biosimilar Contract Manufacturing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biosimilar Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biosimilar Contract Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim Biopharmaceuticals GmbH, Lonza, Catalent, Inc., Biocon, IQVIA Inc., AGC Biologics, Samsung Biologics, WuXi Biologics, Element Materials Technology, Rentschler Biopharma SE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biosimilar Contract Manufacturing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Recombinant Non-glycosylated Proteins
- Recombinant Glycosylated Proteins
Market segment by Application
- Oncology
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic & Autoimmune Disorders
- Rheumatoid Arthritis
- Others
Market segment by players, this report covers
- Boehringer Ingelheim Biopharmaceuticals GmbH
- Lonza
- Catalent, Inc.
- Biocon
- IQVIA Inc.
- AGC Biologics
- Samsung Biologics
- WuXi Biologics
- Element Materials Technology
- Rentschler Biopharma SE
- Avid Bioservices, Inc.
- Alcami Corporation, Inc.
- Fujifilm Kyowa Kirin Biologics Co., Ltd.
- Thermo Fisher Scientific Inc.
- Almac Group
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biosimilar Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilar Contract Manufacturing, with revenue, gross margin, and global market share of Biosimilar Contract Manufacturing from 2020 to 2025.
Chapter 3, the Biosimilar Contract Manufacturing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Biosimilar Contract Manufacturing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar Contract Manufacturing.
Chapter 13, to describe Biosimilar Contract Manufacturing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilar Contract Manufacturing by Type
1.3.1 Overview: Global Biosimilar Contract Manufacturing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Biosimilar Contract Manufacturing Consumption Value Market Share by Type in 2024
1.3.3 Recombinant Non-glycosylated Proteins
1.3.4 Recombinant Glycosylated Proteins
1.4 Global Biosimilar Contract Manufacturing Market by Application
1.4.1 Overview: Global Biosimilar Contract Manufacturing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Oncology
1.4.3 Blood Disorders
1.4.4 Growth Hormonal Deficiency
1.4.5 Chronic & Autoimmune Disorders
1.4.6 Rheumatoid Arthritis
1.4.7 Others
1.5 Global Biosimilar Contract Manufacturing Market Size & Forecast
1.6 Global Biosimilar Contract Manufacturing Market Size and Forecast by Region
1.6.1 Global Biosimilar Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Biosimilar Contract Manufacturing Market Size by Region, (2020-2031)
1.6.3 North America Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.4 Europe Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.6 South America Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Boehringer Ingelheim Biopharmaceuticals GmbH
2.1.1 Boehringer Ingelheim Biopharmaceuticals GmbH Details
2.1.2 Boehringer Ingelheim Biopharmaceuticals GmbH Major Business
2.1.3 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Product and Solutions
2.1.4 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Boehringer Ingelheim Biopharmaceuticals GmbH Recent Developments and Future Plans
2.2 Lonza
2.2.1 Lonza Details
2.2.2 Lonza Major Business
2.2.3 Lonza Biosimilar Contract Manufacturing Product and Solutions
2.2.4 Lonza Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Lonza Recent Developments and Future Plans
2.3 Catalent, Inc.
2.3.1 Catalent, Inc. Details
2.3.2 Catalent, Inc. Major Business
2.3.3 Catalent, Inc. Biosimilar Contract Manufacturing Product and Solutions
2.3.4 Catalent, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Catalent, Inc. Recent Developments and Future Plans
2.4 Biocon
2.4.1 Biocon Details
2.4.2 Biocon Major Business
2.4.3 Biocon Biosimilar Contract Manufacturing Product and Solutions
2.4.4 Biocon Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Biocon Recent Developments and Future Plans
2.5 IQVIA Inc.
2.5.1 IQVIA Inc. Details
2.5.2 IQVIA Inc. Major Business
2.5.3 IQVIA Inc. Biosimilar Contract Manufacturing Product and Solutions
2.5.4 IQVIA Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 IQVIA Inc. Recent Developments and Future Plans
2.6 AGC Biologics
2.6.1 AGC Biologics Details
2.6.2 AGC Biologics Major Business
2.6.3 AGC Biologics Biosimilar Contract Manufacturing Product and Solutions
2.6.4 AGC Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 AGC Biologics Recent Developments and Future Plans
2.7 Samsung Biologics
2.7.1 Samsung Biologics Details
2.7.2 Samsung Biologics Major Business
2.7.3 Samsung Biologics Biosimilar Contract Manufacturing Product and Solutions
2.7.4 Samsung Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Samsung Biologics Recent Developments and Future Plans
2.8 WuXi Biologics
2.8.1 WuXi Biologics Details
2.8.2 WuXi Biologics Major Business
2.8.3 WuXi Biologics Biosimilar Contract Manufacturing Product and Solutions
2.8.4 WuXi Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 WuXi Biologics Recent Developments and Future Plans
2.9 Element Materials Technology
2.9.1 Element Materials Technology Details
2.9.2 Element Materials Technology Major Business
2.9.3 Element Materials Technology Biosimilar Contract Manufacturing Product and Solutions
2.9.4 Element Materials Technology Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Element Materials Technology Recent Developments and Future Plans
2.10 Rentschler Biopharma SE
2.10.1 Rentschler Biopharma SE Details
2.10.2 Rentschler Biopharma SE Major Business
2.10.3 Rentschler Biopharma SE Biosimilar Contract Manufacturing Product and Solutions
2.10.4 Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Rentschler Biopharma SE Recent Developments and Future Plans
2.11 Avid Bioservices, Inc.
2.11.1 Avid Bioservices, Inc. Details
2.11.2 Avid Bioservices, Inc. Major Business
2.11.3 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Product and Solutions
2.11.4 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Avid Bioservices, Inc. Recent Developments and Future Plans
2.12 Alcami Corporation, Inc.
2.12.1 Alcami Corporation, Inc. Details
2.12.2 Alcami Corporation, Inc. Major Business
2.12.3 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Product and Solutions
2.12.4 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Alcami Corporation, Inc. Recent Developments and Future Plans
2.13 Fujifilm Kyowa Kirin Biologics Co., Ltd.
2.13.1 Fujifilm Kyowa Kirin Biologics Co., Ltd. Details
2.13.2 Fujifilm Kyowa Kirin Biologics Co., Ltd. Major Business
2.13.3 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Product and Solutions
2.13.4 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Fujifilm Kyowa Kirin Biologics Co., Ltd. Recent Developments and Future Plans
2.14 Thermo Fisher Scientific Inc.
2.14.1 Thermo Fisher Scientific Inc. Details
2.14.2 Thermo Fisher Scientific Inc. Major Business
2.14.3 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Product and Solutions
2.14.4 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.15 Almac Group
2.15.1 Almac Group Details
2.15.2 Almac Group Major Business
2.15.3 Almac Group Biosimilar Contract Manufacturing Product and Solutions
2.15.4 Almac Group Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Almac Group Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilar Contract Manufacturing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Biosimilar Contract Manufacturing by Company Revenue
3.2.2 Top 3 Biosimilar Contract Manufacturing Players Market Share in 2024
3.2.3 Top 6 Biosimilar Contract Manufacturing Players Market Share in 2024
3.3 Biosimilar Contract Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Biosimilar Contract Manufacturing Market: Region Footprint
3.3.2 Biosimilar Contract Manufacturing Market: Company Product Type Footprint
3.3.3 Biosimilar Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilar Contract Manufacturing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Biosimilar Contract Manufacturing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2025)
5.2 Global Biosimilar Contract Manufacturing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
6.2 North America Biosimilar Contract Manufacturing Market Size by Application (2020-2031)
6.3 North America Biosimilar Contract Manufacturing Market Size by Country
6.3.1 North America Biosimilar Contract Manufacturing Consumption Value by Country (2020-2031)
6.3.2 United States Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
6.3.3 Canada Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
6.3.4 Mexico Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
7.2 Europe Biosimilar Contract Manufacturing Consumption Value by Application (2020-2031)
7.3 Europe Biosimilar Contract Manufacturing Market Size by Country
7.3.1 Europe Biosimilar Contract Manufacturing Consumption Value by Country (2020-2031)
7.3.2 Germany Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.3 France Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.5 Russia Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.6 Italy Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Biosimilar Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Region (2020-2031)
8.3.2 China Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.3 Japan Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.4 South Korea Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.5 India Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.7 Australia Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
9.2 South America Biosimilar Contract Manufacturing Consumption Value by Application (2020-2031)
9.3 South America Biosimilar Contract Manufacturing Market Size by Country
9.3.1 South America Biosimilar Contract Manufacturing Consumption Value by Country (2020-2031)
9.3.2 Brazil Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
9.3.3 Argentina Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Biosimilar Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Country (2020-2031)
10.3.2 Turkey Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
10.3.4 UAE Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Biosimilar Contract Manufacturing Market Drivers
11.2 Biosimilar Contract Manufacturing Market Restraints
11.3 Biosimilar Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilar Contract Manufacturing Industry Chain
12.2 Biosimilar Contract Manufacturing Upstream Analysis
12.3 Biosimilar Contract Manufacturing Midstream Analysis
12.4 Biosimilar Contract Manufacturing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilar Contract Manufacturing by Type
1.3.1 Overview: Global Biosimilar Contract Manufacturing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Biosimilar Contract Manufacturing Consumption Value Market Share by Type in 2024
1.3.3 Recombinant Non-glycosylated Proteins
1.3.4 Recombinant Glycosylated Proteins
1.4 Global Biosimilar Contract Manufacturing Market by Application
1.4.1 Overview: Global Biosimilar Contract Manufacturing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Oncology
1.4.3 Blood Disorders
1.4.4 Growth Hormonal Deficiency
1.4.5 Chronic & Autoimmune Disorders
1.4.6 Rheumatoid Arthritis
1.4.7 Others
1.5 Global Biosimilar Contract Manufacturing Market Size & Forecast
1.6 Global Biosimilar Contract Manufacturing Market Size and Forecast by Region
1.6.1 Global Biosimilar Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Biosimilar Contract Manufacturing Market Size by Region, (2020-2031)
1.6.3 North America Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.4 Europe Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.6 South America Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Biosimilar Contract Manufacturing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Boehringer Ingelheim Biopharmaceuticals GmbH
2.1.1 Boehringer Ingelheim Biopharmaceuticals GmbH Details
2.1.2 Boehringer Ingelheim Biopharmaceuticals GmbH Major Business
2.1.3 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Product and Solutions
2.1.4 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Boehringer Ingelheim Biopharmaceuticals GmbH Recent Developments and Future Plans
2.2 Lonza
2.2.1 Lonza Details
2.2.2 Lonza Major Business
2.2.3 Lonza Biosimilar Contract Manufacturing Product and Solutions
2.2.4 Lonza Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Lonza Recent Developments and Future Plans
2.3 Catalent, Inc.
2.3.1 Catalent, Inc. Details
2.3.2 Catalent, Inc. Major Business
2.3.3 Catalent, Inc. Biosimilar Contract Manufacturing Product and Solutions
2.3.4 Catalent, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Catalent, Inc. Recent Developments and Future Plans
2.4 Biocon
2.4.1 Biocon Details
2.4.2 Biocon Major Business
2.4.3 Biocon Biosimilar Contract Manufacturing Product and Solutions
2.4.4 Biocon Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Biocon Recent Developments and Future Plans
2.5 IQVIA Inc.
2.5.1 IQVIA Inc. Details
2.5.2 IQVIA Inc. Major Business
2.5.3 IQVIA Inc. Biosimilar Contract Manufacturing Product and Solutions
2.5.4 IQVIA Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 IQVIA Inc. Recent Developments and Future Plans
2.6 AGC Biologics
2.6.1 AGC Biologics Details
2.6.2 AGC Biologics Major Business
2.6.3 AGC Biologics Biosimilar Contract Manufacturing Product and Solutions
2.6.4 AGC Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 AGC Biologics Recent Developments and Future Plans
2.7 Samsung Biologics
2.7.1 Samsung Biologics Details
2.7.2 Samsung Biologics Major Business
2.7.3 Samsung Biologics Biosimilar Contract Manufacturing Product and Solutions
2.7.4 Samsung Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Samsung Biologics Recent Developments and Future Plans
2.8 WuXi Biologics
2.8.1 WuXi Biologics Details
2.8.2 WuXi Biologics Major Business
2.8.3 WuXi Biologics Biosimilar Contract Manufacturing Product and Solutions
2.8.4 WuXi Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 WuXi Biologics Recent Developments and Future Plans
2.9 Element Materials Technology
2.9.1 Element Materials Technology Details
2.9.2 Element Materials Technology Major Business
2.9.3 Element Materials Technology Biosimilar Contract Manufacturing Product and Solutions
2.9.4 Element Materials Technology Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Element Materials Technology Recent Developments and Future Plans
2.10 Rentschler Biopharma SE
2.10.1 Rentschler Biopharma SE Details
2.10.2 Rentschler Biopharma SE Major Business
2.10.3 Rentschler Biopharma SE Biosimilar Contract Manufacturing Product and Solutions
2.10.4 Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Rentschler Biopharma SE Recent Developments and Future Plans
2.11 Avid Bioservices, Inc.
2.11.1 Avid Bioservices, Inc. Details
2.11.2 Avid Bioservices, Inc. Major Business
2.11.3 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Product and Solutions
2.11.4 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Avid Bioservices, Inc. Recent Developments and Future Plans
2.12 Alcami Corporation, Inc.
2.12.1 Alcami Corporation, Inc. Details
2.12.2 Alcami Corporation, Inc. Major Business
2.12.3 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Product and Solutions
2.12.4 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Alcami Corporation, Inc. Recent Developments and Future Plans
2.13 Fujifilm Kyowa Kirin Biologics Co., Ltd.
2.13.1 Fujifilm Kyowa Kirin Biologics Co., Ltd. Details
2.13.2 Fujifilm Kyowa Kirin Biologics Co., Ltd. Major Business
2.13.3 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Product and Solutions
2.13.4 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Fujifilm Kyowa Kirin Biologics Co., Ltd. Recent Developments and Future Plans
2.14 Thermo Fisher Scientific Inc.
2.14.1 Thermo Fisher Scientific Inc. Details
2.14.2 Thermo Fisher Scientific Inc. Major Business
2.14.3 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Product and Solutions
2.14.4 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.15 Almac Group
2.15.1 Almac Group Details
2.15.2 Almac Group Major Business
2.15.3 Almac Group Biosimilar Contract Manufacturing Product and Solutions
2.15.4 Almac Group Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Almac Group Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilar Contract Manufacturing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Biosimilar Contract Manufacturing by Company Revenue
3.2.2 Top 3 Biosimilar Contract Manufacturing Players Market Share in 2024
3.2.3 Top 6 Biosimilar Contract Manufacturing Players Market Share in 2024
3.3 Biosimilar Contract Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Biosimilar Contract Manufacturing Market: Region Footprint
3.3.2 Biosimilar Contract Manufacturing Market: Company Product Type Footprint
3.3.3 Biosimilar Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilar Contract Manufacturing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Biosimilar Contract Manufacturing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2025)
5.2 Global Biosimilar Contract Manufacturing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
6.2 North America Biosimilar Contract Manufacturing Market Size by Application (2020-2031)
6.3 North America Biosimilar Contract Manufacturing Market Size by Country
6.3.1 North America Biosimilar Contract Manufacturing Consumption Value by Country (2020-2031)
6.3.2 United States Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
6.3.3 Canada Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
6.3.4 Mexico Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
7.2 Europe Biosimilar Contract Manufacturing Consumption Value by Application (2020-2031)
7.3 Europe Biosimilar Contract Manufacturing Market Size by Country
7.3.1 Europe Biosimilar Contract Manufacturing Consumption Value by Country (2020-2031)
7.3.2 Germany Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.3 France Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.5 Russia Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.6 Italy Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Biosimilar Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Region (2020-2031)
8.3.2 China Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.3 Japan Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.4 South Korea Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.5 India Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.7 Australia Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
9.2 South America Biosimilar Contract Manufacturing Consumption Value by Application (2020-2031)
9.3 South America Biosimilar Contract Manufacturing Market Size by Country
9.3.1 South America Biosimilar Contract Manufacturing Consumption Value by Country (2020-2031)
9.3.2 Brazil Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
9.3.3 Argentina Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Biosimilar Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Country (2020-2031)
10.3.2 Turkey Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
10.3.4 UAE Biosimilar Contract Manufacturing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Biosimilar Contract Manufacturing Market Drivers
11.2 Biosimilar Contract Manufacturing Market Restraints
11.3 Biosimilar Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilar Contract Manufacturing Industry Chain
12.2 Biosimilar Contract Manufacturing Upstream Analysis
12.3 Biosimilar Contract Manufacturing Midstream Analysis
12.4 Biosimilar Contract Manufacturing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biosimilar Contract Manufacturing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Biosimilar Contract Manufacturing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Biosimilar Contract Manufacturing Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Biosimilar Contract Manufacturing Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Boehringer Ingelheim Biopharmaceuticals GmbH Company Information, Head Office, and Major Competitors
Table 6. Boehringer Ingelheim Biopharmaceuticals GmbH Major Business
Table 7. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Product and Solutions
Table 8. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Boehringer Ingelheim Biopharmaceuticals GmbH Recent Developments and Future Plans
Table 10. Lonza Company Information, Head Office, and Major Competitors
Table 11. Lonza Major Business
Table 12. Lonza Biosimilar Contract Manufacturing Product and Solutions
Table 13. Lonza Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Lonza Recent Developments and Future Plans
Table 15. Catalent, Inc. Company Information, Head Office, and Major Competitors
Table 16. Catalent, Inc. Major Business
Table 17. Catalent, Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 18. Catalent, Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Biocon Company Information, Head Office, and Major Competitors
Table 20. Biocon Major Business
Table 21. Biocon Biosimilar Contract Manufacturing Product and Solutions
Table 22. Biocon Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Biocon Recent Developments and Future Plans
Table 24. IQVIA Inc. Company Information, Head Office, and Major Competitors
Table 25. IQVIA Inc. Major Business
Table 26. IQVIA Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 27. IQVIA Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. IQVIA Inc. Recent Developments and Future Plans
Table 29. AGC Biologics Company Information, Head Office, and Major Competitors
Table 30. AGC Biologics Major Business
Table 31. AGC Biologics Biosimilar Contract Manufacturing Product and Solutions
Table 32. AGC Biologics Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. AGC Biologics Recent Developments and Future Plans
Table 34. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 35. Samsung Biologics Major Business
Table 36. Samsung Biologics Biosimilar Contract Manufacturing Product and Solutions
Table 37. Samsung Biologics Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Samsung Biologics Recent Developments and Future Plans
Table 39. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 40. WuXi Biologics Major Business
Table 41. WuXi Biologics Biosimilar Contract Manufacturing Product and Solutions
Table 42. WuXi Biologics Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. WuXi Biologics Recent Developments and Future Plans
Table 44. Element Materials Technology Company Information, Head Office, and Major Competitors
Table 45. Element Materials Technology Major Business
Table 46. Element Materials Technology Biosimilar Contract Manufacturing Product and Solutions
Table 47. Element Materials Technology Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Element Materials Technology Recent Developments and Future Plans
Table 49. Rentschler Biopharma SE Company Information, Head Office, and Major Competitors
Table 50. Rentschler Biopharma SE Major Business
Table 51. Rentschler Biopharma SE Biosimilar Contract Manufacturing Product and Solutions
Table 52. Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Rentschler Biopharma SE Recent Developments and Future Plans
Table 54. Avid Bioservices, Inc. Company Information, Head Office, and Major Competitors
Table 55. Avid Bioservices, Inc. Major Business
Table 56. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 57. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Avid Bioservices, Inc. Recent Developments and Future Plans
Table 59. Alcami Corporation, Inc. Company Information, Head Office, and Major Competitors
Table 60. Alcami Corporation, Inc. Major Business
Table 61. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 62. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Alcami Corporation, Inc. Recent Developments and Future Plans
Table 64. Fujifilm Kyowa Kirin Biologics Co., Ltd. Company Information, Head Office, and Major Competitors
Table 65. Fujifilm Kyowa Kirin Biologics Co., Ltd. Major Business
Table 66. Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Product and Solutions
Table 67. Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Fujifilm Kyowa Kirin Biologics Co., Ltd. Recent Developments and Future Plans
Table 69. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 70. Thermo Fisher Scientific Inc. Major Business
Table 71. Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 72. Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 74. Almac Group Company Information, Head Office, and Major Competitors
Table 75. Almac Group Major Business
Table 76. Almac Group Biosimilar Contract Manufacturing Product and Solutions
Table 77. Almac Group Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Almac Group Recent Developments and Future Plans
Table 79. Global Biosimilar Contract Manufacturing Revenue (USD Million) by Players (2020-2025)
Table 80. Global Biosimilar Contract Manufacturing Revenue Share by Players (2020-2025)
Table 81. Breakdown of Biosimilar Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Biosimilar Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 83. Head Office of Key Biosimilar Contract Manufacturing Players
Table 84. Biosimilar Contract Manufacturing Market: Company Product Type Footprint
Table 85. Biosimilar Contract Manufacturing Market: Company Product Application Footprint
Table 86. Biosimilar Contract Manufacturing New Market Entrants and Barriers to Market Entry
Table 87. Biosimilar Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Biosimilar Contract Manufacturing Consumption Value (USD Million) by Type (2020-2025)
Table 89. Global Biosimilar Contract Manufacturing Consumption Value Share by Type (2020-2025)
Table 90. Global Biosimilar Contract Manufacturing Consumption Value Forecast by Type (2026-2031)
Table 91. Global Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025)
Table 92. Global Biosimilar Contract Manufacturing Consumption Value Forecast by Application (2026-2031)
Table 93. North America Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 94. North America Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 95. North America Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 96. North America Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 97. North America Biosimilar Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Biosimilar Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 100. Europe Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 101. Europe Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 102. Europe Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 103. Europe Biosimilar Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 104. Europe Biosimilar Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 105. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 106. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 107. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Region (2020-2025) & (USD Million)
Table 110. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Region (2026-2031) & (USD Million)
Table 111. South America Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 112. South America Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 113. South America Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 114. South America Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 115. South America Biosimilar Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 116. South America Biosimilar Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 118. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 119. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 120. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 121. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 122. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Global Key Players of Biosimilar Contract Manufacturing Upstream (Raw Materials)
Table 124. Global Biosimilar Contract Manufacturing Typical Customers
Table 1. Global Biosimilar Contract Manufacturing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Biosimilar Contract Manufacturing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Biosimilar Contract Manufacturing Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Biosimilar Contract Manufacturing Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Boehringer Ingelheim Biopharmaceuticals GmbH Company Information, Head Office, and Major Competitors
Table 6. Boehringer Ingelheim Biopharmaceuticals GmbH Major Business
Table 7. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Product and Solutions
Table 8. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Boehringer Ingelheim Biopharmaceuticals GmbH Recent Developments and Future Plans
Table 10. Lonza Company Information, Head Office, and Major Competitors
Table 11. Lonza Major Business
Table 12. Lonza Biosimilar Contract Manufacturing Product and Solutions
Table 13. Lonza Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Lonza Recent Developments and Future Plans
Table 15. Catalent, Inc. Company Information, Head Office, and Major Competitors
Table 16. Catalent, Inc. Major Business
Table 17. Catalent, Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 18. Catalent, Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Biocon Company Information, Head Office, and Major Competitors
Table 20. Biocon Major Business
Table 21. Biocon Biosimilar Contract Manufacturing Product and Solutions
Table 22. Biocon Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Biocon Recent Developments and Future Plans
Table 24. IQVIA Inc. Company Information, Head Office, and Major Competitors
Table 25. IQVIA Inc. Major Business
Table 26. IQVIA Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 27. IQVIA Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. IQVIA Inc. Recent Developments and Future Plans
Table 29. AGC Biologics Company Information, Head Office, and Major Competitors
Table 30. AGC Biologics Major Business
Table 31. AGC Biologics Biosimilar Contract Manufacturing Product and Solutions
Table 32. AGC Biologics Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. AGC Biologics Recent Developments and Future Plans
Table 34. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 35. Samsung Biologics Major Business
Table 36. Samsung Biologics Biosimilar Contract Manufacturing Product and Solutions
Table 37. Samsung Biologics Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Samsung Biologics Recent Developments and Future Plans
Table 39. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 40. WuXi Biologics Major Business
Table 41. WuXi Biologics Biosimilar Contract Manufacturing Product and Solutions
Table 42. WuXi Biologics Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. WuXi Biologics Recent Developments and Future Plans
Table 44. Element Materials Technology Company Information, Head Office, and Major Competitors
Table 45. Element Materials Technology Major Business
Table 46. Element Materials Technology Biosimilar Contract Manufacturing Product and Solutions
Table 47. Element Materials Technology Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Element Materials Technology Recent Developments and Future Plans
Table 49. Rentschler Biopharma SE Company Information, Head Office, and Major Competitors
Table 50. Rentschler Biopharma SE Major Business
Table 51. Rentschler Biopharma SE Biosimilar Contract Manufacturing Product and Solutions
Table 52. Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Rentschler Biopharma SE Recent Developments and Future Plans
Table 54. Avid Bioservices, Inc. Company Information, Head Office, and Major Competitors
Table 55. Avid Bioservices, Inc. Major Business
Table 56. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 57. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Avid Bioservices, Inc. Recent Developments and Future Plans
Table 59. Alcami Corporation, Inc. Company Information, Head Office, and Major Competitors
Table 60. Alcami Corporation, Inc. Major Business
Table 61. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 62. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Alcami Corporation, Inc. Recent Developments and Future Plans
Table 64. Fujifilm Kyowa Kirin Biologics Co., Ltd. Company Information, Head Office, and Major Competitors
Table 65. Fujifilm Kyowa Kirin Biologics Co., Ltd. Major Business
Table 66. Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Product and Solutions
Table 67. Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Fujifilm Kyowa Kirin Biologics Co., Ltd. Recent Developments and Future Plans
Table 69. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 70. Thermo Fisher Scientific Inc. Major Business
Table 71. Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Product and Solutions
Table 72. Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 74. Almac Group Company Information, Head Office, and Major Competitors
Table 75. Almac Group Major Business
Table 76. Almac Group Biosimilar Contract Manufacturing Product and Solutions
Table 77. Almac Group Biosimilar Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Almac Group Recent Developments and Future Plans
Table 79. Global Biosimilar Contract Manufacturing Revenue (USD Million) by Players (2020-2025)
Table 80. Global Biosimilar Contract Manufacturing Revenue Share by Players (2020-2025)
Table 81. Breakdown of Biosimilar Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Biosimilar Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 83. Head Office of Key Biosimilar Contract Manufacturing Players
Table 84. Biosimilar Contract Manufacturing Market: Company Product Type Footprint
Table 85. Biosimilar Contract Manufacturing Market: Company Product Application Footprint
Table 86. Biosimilar Contract Manufacturing New Market Entrants and Barriers to Market Entry
Table 87. Biosimilar Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Biosimilar Contract Manufacturing Consumption Value (USD Million) by Type (2020-2025)
Table 89. Global Biosimilar Contract Manufacturing Consumption Value Share by Type (2020-2025)
Table 90. Global Biosimilar Contract Manufacturing Consumption Value Forecast by Type (2026-2031)
Table 91. Global Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025)
Table 92. Global Biosimilar Contract Manufacturing Consumption Value Forecast by Application (2026-2031)
Table 93. North America Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 94. North America Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 95. North America Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 96. North America Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 97. North America Biosimilar Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Biosimilar Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 100. Europe Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 101. Europe Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 102. Europe Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 103. Europe Biosimilar Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 104. Europe Biosimilar Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 105. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 106. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 107. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Region (2020-2025) & (USD Million)
Table 110. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value by Region (2026-2031) & (USD Million)
Table 111. South America Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 112. South America Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 113. South America Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 114. South America Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 115. South America Biosimilar Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 116. South America Biosimilar Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Type (2020-2025) & (USD Million)
Table 118. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Type (2026-2031) & (USD Million)
Table 119. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 120. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 121. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 122. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Global Key Players of Biosimilar Contract Manufacturing Upstream (Raw Materials)
Table 124. Global Biosimilar Contract Manufacturing Typical Customers
LIST OF FIGURES
Figure 1. Biosimilar Contract Manufacturing Picture
Figure 2. Global Biosimilar Contract Manufacturing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Biosimilar Contract Manufacturing Consumption Value Market Share by Type in 2024
Figure 4. Recombinant Non-glycosylated Proteins
Figure 5. Recombinant Glycosylated Proteins
Figure 6. Global Biosimilar Contract Manufacturing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Biosimilar Contract Manufacturing Consumption Value Market Share by Application in 2024
Figure 8. Oncology Picture
Figure 9. Blood Disorders Picture
Figure 10. Growth Hormonal Deficiency Picture
Figure 11. Chronic & Autoimmune Disorders Picture
Figure 12. Rheumatoid Arthritis Picture
Figure 13. Others Picture
Figure 14. Global Biosimilar Contract Manufacturing Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Biosimilar Contract Manufacturing Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Biosimilar Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Biosimilar Contract Manufacturing Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Biosimilar Contract Manufacturing Consumption Value Market Share by Region in 2024
Figure 19. North America Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Biosimilar Contract Manufacturing Revenue Share by Players in 2024
Figure 26. Biosimilar Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Biosimilar Contract Manufacturing by Player Revenue in 2024
Figure 28. Top 3 Biosimilar Contract Manufacturing Players Market Share in 2024
Figure 29. Top 6 Biosimilar Contract Manufacturing Players Market Share in 2024
Figure 30. Global Biosimilar Contract Manufacturing Consumption Value Share by Type (2020-2025)
Figure 31. Global Biosimilar Contract Manufacturing Market Share Forecast by Type (2026-2031)
Figure 32. Global Biosimilar Contract Manufacturing Consumption Value Share by Application (2020-2025)
Figure 33. Global Biosimilar Contract Manufacturing Market Share Forecast by Application (2026-2031)
Figure 34. North America Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Biosimilar Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Biosimilar Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 44. France Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value Market Share by Region (2020-2031)
Figure 51. China Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 54. India Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Biosimilar Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 68. Biosimilar Contract Manufacturing Market Drivers
Figure 69. Biosimilar Contract Manufacturing Market Restraints
Figure 70. Biosimilar Contract Manufacturing Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Biosimilar Contract Manufacturing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Biosimilar Contract Manufacturing Picture
Figure 2. Global Biosimilar Contract Manufacturing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Biosimilar Contract Manufacturing Consumption Value Market Share by Type in 2024
Figure 4. Recombinant Non-glycosylated Proteins
Figure 5. Recombinant Glycosylated Proteins
Figure 6. Global Biosimilar Contract Manufacturing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Biosimilar Contract Manufacturing Consumption Value Market Share by Application in 2024
Figure 8. Oncology Picture
Figure 9. Blood Disorders Picture
Figure 10. Growth Hormonal Deficiency Picture
Figure 11. Chronic & Autoimmune Disorders Picture
Figure 12. Rheumatoid Arthritis Picture
Figure 13. Others Picture
Figure 14. Global Biosimilar Contract Manufacturing Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Biosimilar Contract Manufacturing Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Biosimilar Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Biosimilar Contract Manufacturing Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Biosimilar Contract Manufacturing Consumption Value Market Share by Region in 2024
Figure 19. North America Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Biosimilar Contract Manufacturing Revenue Share by Players in 2024
Figure 26. Biosimilar Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Biosimilar Contract Manufacturing by Player Revenue in 2024
Figure 28. Top 3 Biosimilar Contract Manufacturing Players Market Share in 2024
Figure 29. Top 6 Biosimilar Contract Manufacturing Players Market Share in 2024
Figure 30. Global Biosimilar Contract Manufacturing Consumption Value Share by Type (2020-2025)
Figure 31. Global Biosimilar Contract Manufacturing Market Share Forecast by Type (2026-2031)
Figure 32. Global Biosimilar Contract Manufacturing Consumption Value Share by Application (2020-2025)
Figure 33. Global Biosimilar Contract Manufacturing Market Share Forecast by Application (2026-2031)
Figure 34. North America Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Biosimilar Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Biosimilar Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 44. France Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Biosimilar Contract Manufacturing Consumption Value Market Share by Region (2020-2031)
Figure 51. China Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 54. India Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Biosimilar Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Biosimilar Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Biosimilar Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 68. Biosimilar Contract Manufacturing Market Drivers
Figure 69. Biosimilar Contract Manufacturing Market Restraints
Figure 70. Biosimilar Contract Manufacturing Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Biosimilar Contract Manufacturing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
More Publications
Global API Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
June 2022
121 pages
Global Varistors Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
September 2022
113 pages
Global ICT Functional Test Probe Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
June 2022
120 pages
Global Geographic Information Systems (GIS) Market 2022 by Company, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
July 2022
87 pages
Global ACA Tracking and Reporting Market 2025 by Company, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
June 2025
140 pages
